By admin | Published:
January 27, 2008
Robert Mayer
ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and pancreas cancers.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Posted in Oncology | Tagged cancer, colorectal, dana farber cancer institute, gastrointestinal, liver, Oncology, pancreas, robert mayer, symposium, therapies, therapy |
By admin | Published:
January 27, 2008
Eugene Schiff
REFERENCE: General Session IV
EUGENE SCHIFF, University of Miami
Screening for Hepatitits C and B, and subsequent screening for cancer, can save millions of lives from hepatocellular carcinoma. Eugene Schiff told the Gastrointestinal Cancers Conference in Orlando which populations are most at risk. He discussed his data with Peter Goodwin.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
January 27, 2008
Charles Hsu
CHARLES HSU, Johns Hopkins University, Baltimore
Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin about their findings from more than 1,000 patients.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Posted in Oncology | Tagged cancer, cancers, charles hsu, chemotherapy, conference, findings, improvements, johns hopkins university, mp3, Oncology, pancreas cancer, patient, podcast, radiation, report, survival |
By admin | Published:
January 26, 2008
William Blot
REFERENCE: General Session 1: Cancers of the Esophagus and Stomach
WILLIAM BLOT, Vanderbilt University, Nashville TN
Obesity emerged as a key cause of esophageal cancer from data presented by William Blot who told Peter Goodwin about the changing pattern of both esophageal and stomach cancer throughout the world, and about the likely ways of preventing them.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
By admin | Published:
January 11, 2008
Colin Baigent
REFERENCE: Lancet 371:117 January 11, 2008
COLIN BAIGENT, Oxford University
Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in a meta-analysis of 18 000 patients from Oxford University in England and the University of Sydney in Australia. Peter Goodwin asked the lead UK investigator, Colin Baigent, about the findings and their implications.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Buy + Download Now This Interview
Posted in Medicine | Tagged cardiovascular, colin baigent, diabetes, diabetic, download, findings, interview, investigation, lancet, meta analysis, oxford university, patient, podcast, statin, type ii diabetes |
By admin | Published:
January 8, 2008
Richard Peto
REFERENCE: Lancet 371:29-40; January 5, 2008
RICHARD PETO, Oxford University
The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He talks with Peter Goodwin following the group’s most recent publication in The Lancet.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Buy + Download Now This Interview
Posted in News | Tagged breast, cancer, chemotherapy, collaborative group, findings, iphone, lancet, mortality, Oncology, oxford university, peter goodwin, podcast, podcasting, prospects, richard peto |
By admin | Published:
January 4, 2008
Peter Tyrer
REFERENCE: Lancet 371:57 January 5, 2008
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as “aggressive challenging behaviour” has shown that the anti-psychotic medicines gave no benefit. Peter Goodwin met up with Professor Peter Tyrer at London’s Imperial College to ask him about the study.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.
Buy + Download Now This Interview
Posted in Medicine | Tagged aggressive, drug, drugs, lancet, london, medicine, patient, placebo, podcasting, study, syndrome, treatment |
